Glucagon assays and 1 more item

On August 1, 2026, the University of Virginia awarded contract A207_PO-0322357-V3 to Vanderbilt University Medical Center, a Virginia-based prime contractor. The contract encompasses the supply of clinical assay materials with a cumulative value of $59,550.10. The contracting organization, University of Virginia, serves as the procuring entity for this state-level award within Virginia.

The contract deliverables consist of two primary line items: 33,757 units of glucagon assays and 25,792 units of insulin assays, each priced at $1.00 per unit. These diagnostic assay materials are to be delivered to the buyer as specified in the purchase order. The supplies support laboratory and clinical testing capabilities, consistent with the medical and research missions of academic medical institutions. No specific performance period end date is provided in the available contract documentation.